We recently demonstrated that 2,3,4,5,6-pentahydroxyxanthone (X5) inhi
bits the in vitro growth of both chloroquine-sensitive and multidrug-r
esistant strains of P. falciparum. To study the molecular basis of its
antimalarial action, we tested X5 and selected hydroxyxanthone analog
s as inhibitors of in vitro heme polymerization in a low ionic strengt
h phosphate solution at mildly acidic pH, We found that addition of 1
Eq. of X5 resulted in complete inhibition of polymerization in this sy
stem whereas addition of up to 40 Eqs. of standard antimalarial compou
nds (chloroquine, primaquine, quinacrine, artemisinin and methylene bl
ue) had no such effect although these compounds did co-precipitate wit
h heme. The antimalarial potency of the hydroxyxanthones correlated we
ll with their ability to inhibit in vitro heme polymerization in our a
ssay, suggesting that these compounds exert their antimalarial action
by preventing hemozoin formation, Based on the observed structure-acti
vity relationships, we propose a model displaying possible interaction
s between hydroxyxanthones and heme. (C) 1997 Federation of European B
iochemical Societies.